Elisa Oricchio

Elisa Oricchio

UNVERIFIED PROFILE

Are you Elisa Oricchio?   Register this Author

Register author
Elisa Oricchio

Elisa Oricchio

Publications by authors named "Elisa Oricchio"

Are you Elisa Oricchio?   Register this Author

17Publications

-Reads

Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma.

Blood 2018 May 22;131(21):2345-2356. Epub 2018 Mar 22.

Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

View Article
May 2018

Sestrin1, a tumor suppressor that can be rescued.

Mol Cell Oncol 2017 21;4(6):e1365107. Epub 2017 Sep 21.

Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

View Article
September 2017

Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies.

Cancer Cell 2017 08 27;32(2):155-168.e6. Epub 2017 Jul 27.

Department of Computational Biology, University of Lausanne (UNIL), 1011 Lausanne, Vaud, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland. Electronic address:

View Article
August 2017

Generation and characterization of a single-chain anti-EphA2 antibody.

Growth Factors 2014 Dec 19;32(6):214-22. Epub 2014 Nov 19.

Structural Biology Program, Memorial Sloan-Kettering Cancer Center , New York, NY , USA .

View Article
December 2014

A cell engineering strategy to enhance the safety of stem cell therapies.

Cell Rep 2014 Sep 18;8(6):1677-1685. Epub 2014 Sep 18.

Cancer Biology & Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article
September 2014

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.

J Exp Med 2014 Jun 9;211(7):1379-91. Epub 2014 Jun 9.

Cancer Biology & Genetics Program, Computational Biology Program, Department of Medicine, Human Oncology and Pathogenesis Program, Genomics Core Facility, Molecular Pharmacology Program, Department of Pathology, Department of Epidemiology and Biostatistics, and Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065

View Article
June 2014

Progress against follicular lymphoma.

Curr Opin Hematol 2013 Jul;20(4):320-6

Department of Medicine, University of Arizona, Tucson, Arizona, USA.

View Article
July 2013

Functional genomics lead to new therapies in follicular lymphoma.

Ann N Y Acad Sci 2013 Jul 15;1293:18-24. Epub 2013 May 15.

Cancer Biology & Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article
July 2013

Mining the cancer genome uncovers therapeutic activity of EphA7 against lymphoma.

Cell Cycle 2012 Mar 15;11(6):1076-80. Epub 2012 Mar 15.

Cancer Biology & Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article
March 2012

Mouse models of cancer as biological filters for complex genomic data.

Dis Model Mech 2010 Nov-Dec;3(11-12):701-4. Epub 2010 Sep 27.

Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article
February 2011

Endogenous reverse transcriptase as a mediator of ursolic acid's anti-proliferative and differentiating effects in human cancer cell lines.

Cancer Lett 2008 May 20;263(1):130-9. Epub 2008 Feb 20.

Pharmaco-Biological Department, School of Pharmacy, University of Messina, Vill. SS. Annunziata, 98168 Messina, Italy.

View Article
May 2008

ATM is activated by default in mitosis, localizes at centrosomes and monitors mitotic spindle integrity.

Cell Cycle 2006 Jan 21;5(1):88-92. Epub 2006 Jan 21.

Institute of Biology and Molecular Pathology, National Research Council, Rome, Italy.

View Article
January 2006